戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                    Lead toxicity can lead to gouty arthritis (gout), but whether the low lead exposur
2 eatment for inflammatory diseases, including gouty arthritis and familial Mediterranean fever.
3 cid has been long recognized as the cause of gouty arthritis and kidney stones.
4 eas the incidence of other disorders such as gouty arthritis and malignant cancers is higher in men.
5 DL-all-rac-alpha-tocopherol alleviated acute gouty arthritis and MSU-induced peritonitis.
6  mechanism of action of ACTH in experimental gouty arthritis and points to a novel antiinflammatory t
7 s at MC3-R) for clinical management of human gouty arthritis and possibly other chronic inflammatory
8 ant levels of asymptomatic hyperuricemia and gouty arthritis can ultimately clarify this issue.
9 XOIs) paradoxically causes early increase in gouty arthritis flares.
10  of the drugs we use to manage patients with gouty arthritis have been in existence since the 1970s a
11  management, and pathophysiology of gout and gouty arthritis have been recently reviewed.
12 f human neutrophils and reduced experimental gouty arthritis in mice.
13                                              Gouty arthritis is associated with an excess risk of acu
14 neutrophil recruitment in experimental acute gouty arthritis of the rabbit knee.
15 nically relevant hyperuricaemia (acute gout, gouty arthritis or initiation of anti-gout therapy) by 3
16 has been incriminated in the pathogenesis of gouty arthritis, Alzheimer's, and silicosis.
17 syndrome (CAPS), neurodegenerative diseases, gouty arthritis, and numerous others.
18 ypical MRI findings of rheumatoid arthritis, gouty arthritis, calcium pyrophosphate deposition diseas
19                       Finally, in a model of gouty arthritis, direct injection of urate crystals into
20                This is a discussion of acute gouty arthritis, seen for over 50 years of engagement.
21 sis of a number of human diseases, including gouty arthritis, silicosis, atherosclerosis, and type 2
22 itis, such as juvenile chronic arthritis and gouty arthritis, that may have a variable appearance com
23 osis and contributing to the pathogenesis of gouty arthritis.
24 al of MSU crystal deposits and the course of gouty arthritis.
25 eutic approaches for hyperuricemia and acute gouty arthritis.
26 lcohol consumption may lead to a decrease in gouty arthritis.
27 , and protected mice from the development of gouty arthritis.
28 hilic response in this in vivo evaluation of gouty arthritis.
29 itis, crystal deposition diseases (including gouty arthropathy and calcium pyrophosphate deposition d
30 lic disorders) and 9 disease outcomes (gout, gouty arthropathy, pyogenic arthritis, essential hyperte
31 ce of factors contributing to development of gouty attacks such as diuretic therapy, weight gain, and
32  may explain some of the uncertainties about gouty attacks.
33 tentially more effective strategies for both gouty inflammation and urate lowering.
34  appreciated centrality of IL-1beta in acute gouty inflammation has prompted studies of agents blocki
35                                     However, gouty inflammation is spontaneously self-limited, an occ
36 ment-emergent serum interactome included key gouty inflammation mediators (C5, IL-1B, CXCL8, IL6).
37 his study, we examined the potential role in gouty inflammation of CD14, a phagocyte-expressed patter
38 ium urate monohydrate (MSU) crystals promote gouty inflammation that is critically mediated by neutro
39 he factors that restrains the progression of gouty inflammation.
40 be noninflammatory and promote resolution of gouty inflammation.
41 al variability in the extent and duration of gouty inflammation.
42 nse protein 88 (MyD88) is required for acute gouty inflammation.
43  proinflammatory responses and trigger acute gouty inflammation.
44 e of IGF-1/IGF1R signaling in the context of gouty inflammation.
45  crystals and key cellular components of the gouty inflammatory paroxysm, with new material on pathog
46  that the innate immune system may drive the gouty inflammatory response to MSU.
47 tudy could lead to a better understanding of gouty joint inflammation and help improve the treatment
48 atively correlated with serum UA level among gouty patients and healthy controls.
49 and unsaturated fat diet was recommended for gouty patients since they all enhance insulin sensitivit
50 nto SCID mice while, simultaneously, diluted gouty SF containing CXCL16, or depleted of CXCL16 by ant
51 SCID mouse chimeras injected intragraft with gouty SF that had been depleted of CXCL16 during PMN tra
52 XCL16 concentrations were highly elevated in gouty SF, and PMNs were observed to migrate in response
53                   Recruitment of PMNs to the gouty SF-injected normal human ST was then examined in t
54  as an active recruitment factor for PMNs in gouty SF.
55 h that after administration of sham-depleted gouty SF.
56 t mediator of in vivo recruitment of PMNs to gouty SF.
57 uced by neutralization of CXCL16 activity in gouty SF.
58                                              Gouty synovitis is driven and sustained by neutrophil in
59 ient referred to us for recurrent chest wall gouty tophus, but who was determined to actually have a